Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 14/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.45 |
| ▸ | CCR4 | P51679 | 1/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7147488 | 0.99 | F2 (0.63) | F2NPSR1SPHK1CCR4ACE | |
| SCHEMBL7102911 | 0.91 | F2 (0.53) | F2NPSR1SPHK1CCR4ACE | |
| SCHEMBL7107001 | 0.88 | CCR4 (0.49) | F2NPSR1SPHK1CCR4ACE | |
| SCHEMBL7102501 | 0.88 | F2 (0.49) | F2NPSR1SPHK1CCR4ACE | |
| SCHEMBL7107383 | 0.86 | F2 (0.55) | F2NPSR1SPHK1CCR4ACE | |
| Hydrochloric Acid SCHEMBL9228074 | 0.86 | F2 (0.56) | F2NPSR1SPHK1CCR4ACE | |
| SCHEMBL7106036 | 0.84 | F2 (0.53) | F2NPSR1 | |
| Hydrochloric Acid SCHEMBL7140906 | 0.83 | F2 (0.54) | F2 | |
| SCHEMBL7101554 | 0.82 | F2 (0.48) | F2NPSR1SPHK1CCR4ACE | |
| SCHEMBL7139834 | 0.81 | F2 (0.49) | F2NPSR1SPHK1CCR4ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1361212-A1 | Peptide derivatives as antithrombotic agents | AstraZeneca AB (SE) | 2003-11-12 | — | — | EP | claimed |
| EP-0672658-A1 | Antithrombotic agents | ELI LILLY AND COMPANY (US) | 1995-09-20 | — | — | EP | claimed |
| WO-1995023609-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1995-09-08 | — | — | WO | claimed |